Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Clinical trial NCT00454818 · COMPLETED
Trial details
- NCT number
- NCT00454818
- Sponsor
- Celladon Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-08-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.